Anne Rullier Selected Research

Anne Rullier Research Topics

Disease

15	Neoplasms (Cancer) 01/2021 - 08/2003
13	Rectal Neoplasms (Rectal Cancer) 10/2021 - 03/2005
5	Neoplasm Metastasis (Metastasis) 10/2021 - 06/2004
5	Hepatocellular Carcinoma (Hepatoma) 08/2009 - 04/2006
4	Carcinoma (Carcinomatosis) 01/2017 - 05/2005
3	Residual Neoplasm 01/2020 - 05/2005
2	Adenocarcinoma 10/2021 - 04/2010
2	Hepatoblastoma 01/2018 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 02/2012 - 09/2007
2	Liver Cell Adenoma (Hepatocellular Adenoma) 03/2009 - 09/2007
2	Fibrosis (Cirrhosis) 03/2009 - 09/2004
2	Body Weight (Weight, Body) 09/2007 - 01/2007
2	Colitis 01/2007 - 11/2005
1	Vascular Diseases (Vascular Disease) 05/2021
1	Atherosclerosis 05/2021
1	Ischemic Stroke 05/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Neoplasm Micrometastasis 07/2015
1	Colonic Neoplasms (Colon Cancer) 07/2015
1	Margins of Excision 01/2013
1	Hemorrhage 08/2009
1	Focal Nodular Hyperplasia 03/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2008
1	Necrosis 01/2008
1	Obesity 09/2007
1	Sepsis (Septicemia) 11/2006
1	Inflammation (Inflammations) 01/2006
1	Carcinogenesis 01/2006
1	Lymphatic Metastasis 06/2004
1	Infections 06/2003
1	Chronic Hepatitis C 06/2003

Drug/Important Bio-Agent (IBA)

4	beta CateninIBA 01/2017 - 09/2007
2	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2017
2	Thrombin FDA Link 01/2008 - 01/2006
2	Matrix Metalloproteinases (MMPs)IBA 01/2007 - 04/2006
1	ParaffinIBA 05/2021
1	Formaldehyde (Formol)FDA Link 05/2021
1	Immune Checkpoint InhibitorsIBA 01/2019
1	IntegrinsIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	VimentinIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	CateninsIBA 01/2017
1	Biological ProductsIBA 01/2017
1	Cetuximab (Erbitux)FDA Link 07/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2013
1	Capecitabine (Xeloda)FDA Link 01/2013
1	Biomarkers (Surrogate Marker)IBA 12/2011
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2009
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 03/2009
1	Fatty Acid-Binding ProteinsIBA 03/2009
1	PAR-1 ReceptorIBA 01/2008
1	Transaminases (Aminotransferases)IBA 01/2008
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2008
1	LigandsIBA 09/2007
1	RetinoidsIBA 09/2007
1	Messenger RNA (mRNA)IBA 09/2007
1	Transcription Factors (Transcription Factor)IBA 09/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2007
1	PPAR deltaIBA 09/2007
1	PPAR gammaIBA 09/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2007
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2007
1	rebamipideIBA 01/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2007
1	Protective AgentsIBA 01/2007
1	SolventsIBA 04/2006
1	halofuginoneIBA 04/2006
1	Thromboplastin (Tissue Factor)IBA 01/2006
1	Proteinase-Activated ReceptorsIBA 01/2006
1	Conditioned Culture MediaIBA 11/2005
1	Colloids (Colloid)IBA 05/2005
1	Carcinoembryonic AntigenIBA 06/2004
1	Protons (Proton)IBA 08/2003
1	Ribavirin (Virazole)FDA LinkGeneric 06/2003

Therapy/Procedure

8	Chemoradiotherapy 10/2021 - 01/2008
8	Neoadjuvant Therapy 10/2021 - 05/2005
6	Radiotherapy 01/2021 - 05/2005
6	Therapeutics 01/2019 - 09/2004
4	Drug Therapy (Chemotherapy) 01/2021 - 05/2005
2	Adjuvant Chemotherapy 07/2015 - 11/2006
2	Proctectomy 05/2013 - 03/2005
1	Induction Chemotherapy 10/2021
1	Carotid Endarterectomy 05/2021
1	Re-Irradiation 01/2021
1	Oral Administration 11/2005
1	Lymph Node Excision (Lymph Node Dissection) 06/2004
1	Induced Hyperthermia (Thermotherapy) 08/2003